help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rubin, J.
Right arrow Articles by Fan, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rubin, J.
Right arrow Articles by Fan, X.
Endocrinology Vol. 139, No. 3 1006-1012
Copyright © 1998 by The Endocrine Society

ARTICLES

Dexamethasone Promotes Expression of Membrane-Bound Macrophage Colony-Stimulating Factor in Murine Osteoblast-Like Cells1

J. Rubin, D. M. Biskobing, L. Jadhav, D. Fan, M. S. Nanes, S. Perkins and X. Fan

Department of Medicine, Emory University, and Veterans Affairs Medical Center, Atlanta, Georgia 30033; and the Department of Pathology, University of Utah (S.P.), Salt Lake City, Utah 84132

Address all correspondence and requests for reprints to: Dr. J. Rubin, Veterans Affairs Medical Center-151, 1670 Clairmont Road, Decatur, Georgia 30033. E-mail: jrubi02{at}emory.edu

The mechanisms by which glucocorticosteroids promote osteoclastogenesis in vitro are uncertain. As macrophage colony-stimulating factor (MCSF) is critical for osteoclastogenesis, we hypothesized that glucocorticosteroids might regulate membrane-bound MCSF (mMCSF) and soluble MCSF (sMCSF) production by stromal cells or osteoblasts. ST2 cells or murine calvarial osteoblasts (MOBs) were treated with dexamethasone (Dex; 100 nM) and/or 1,25-dihydroxyvitamin D [1,25(OH)2D; 10 nM] for 3 days. Control values for mMCSF and sMCSF as units per 100,000 cells were 9 ± 1.4 and 511 ± 56 in ST2 cells and 5.9 ± 0.8 and 379 ± 47 in MOB cells, respectively. Dex increased mMCSF to 156 ± 16% and 143 ± 26% compared with the control value in ST2 and MOB cells, respectively, whereas 1,25-(OH)2D caused increases of 195 ± 16% and 164 ± 21%. In the presence of both Dex and 1,25-(OH)2D, mMCSF increased to 209 ± 24% and 216 ± 26% in the two cell types, respectively. 1,25-(OH)2D caused modest increases in sMCSF, as expected, in both cell types (153 ± 6% and 122 ± 4%). Dex inhibited 1,25-(OH)2D-stimulated sMCSF (115 ± 7% of control) in ST2 cells. Analysis of mMCSF transcript levels by semiquantitative RT-PCR revealed Dex-stimulated increases of 170 ± 11% in ST2 cells and 126 ± 16% in MOB cells compared with the control level. The increased expression of the transcript for sMCSF in the presence of Dex and 1,25-(OH)2D, measured by both RT-PCR and Northern analysis (219 ± 53% and 242%, respectively), despite inhibition of sMCSF protein, indicated that the inhibitory effect of Dex in ST2 cells was posttranscriptional. Half-life studies showed that Dex prolonged MCSF messenger RNA from 2.8 to 7.5 h. These results suggest that Dex influences osteoclastogenesis by increasing the expression of mMCSF by accessory cells in culture.




This article has been cited by other articles:


Home page
 Endocr. Rev.Home page
A. E. Kearns, S. Khosla, and P. J. Kostenuik
Receptor Activator of Nuclear Factor {kappa}B Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease
Endocr. Rev., April 1, 2008; 29(2): 155 - 192.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. Swanson, M. Lorentzon, H. H. Conaway, and U. H. Lerner
Glucocorticoid Regulation of Osteoclast Differentiation and Expression of Receptor Activator of Nuclear Factor-{kappa}B (NF-{kappa}B) Ligand, Osteoprotegerin, and Receptor Activator of NF-{kappa}B in Mouse Calvarial Bones
Endocrinology, July 1, 2006; 147(7): 3613 - 3622.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Rydziel, A. M. Delany, and E. Canalis
AU-Rich Elements in the Collagenase 3 mRNA Mediate Stabilization of the Transcript by Cortisol in Osteoblasts
J. Biol. Chem., February 13, 2004; 279(7): 5397 - 5404.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
X.-M. Dai, X.-H. Zong, V. Sylvestre, and E. R. Stanley
Incomplete restoration of colony-stimulating factor 1 (CSF-1) function in CSF-1-deficient Csf1op/Csf1op mice by transgenic expression of cell surface CSF-1
Blood, February 1, 2004; 103(3): 1114 - 1123.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
E. Sapi
The Role of CSF-1 in Normal Physiology of Mammary Gland and Breast Cancer: An Update
Experimental Biology and Medicine, January 1, 2004; 229(1): 1 - 11.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Takuma, T. Kaneda, T. Sato, S. Ninomiya, M. Kumegawa, and Y. Hakeda
Dexamethasone Enhances Osteoclast Formation Synergistically with Transforming Growth Factor-{beta} by Stimulating the Priming of Osteoclast Progenitors for Differentiation into Osteoclasts
J. Biol. Chem., November 7, 2003; 278(45): 44667 - 44674.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. Canalis and A. Giustina
Glucocorticoid-Induced Osteoporosis: Summary of a Workshop
J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5681 - 5685.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
X. Fan, D. Fan, H. Gewant, C. L. Royce, M. S. Nanes, and J. Rubin
Increasing membrane-bound MCSF does not enhance OPGL-driven osteoclastogenesis from marrow cells
Am J Physiol Endocrinol Metab, January 1, 2001; 280(1): E103 - E111.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
K. L. Bost, J. L. Bento, J. K. Ellington, I. Marriott, and M. C. Hudson
Induction of Colony-Stimulating Factor Expression following Staphylococcus or Salmonella Interaction with Mouse or Human Osteoblasts
Infect. Immun., September 1, 2000; 68(9): 5075 - 5083.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. F. Goldstein, J. J. Fallon Jr, and R. Harning
Chronic Glucocorticoid Therapy-Induced Osteoporosis in Patients With Obstructive Lung Disease*
Chest, December 1, 1999; 116(6): 1733 - 1749.
[Abstract] [Full Text] [PDF]

Home page
 J Intensive Care MedHome page
I. R. Reid
Glucocorticoid Osteoporosis: Reid IR Glucocorticoid osteoporosis J Intensive Care Med 1999, 14231-242
J Intensive Care Med, September 1, 1999; 14(5): 231 - 242.
[PDF]

Home page
 EndocrinologyHome page
C. K. Lea, U. Sarma, and A. M. Flanagan
Macrophage Colony Stimulating-Factor Transcripts Are Differentially Regulated in Rat Bone-Marrow by Gender Hormones
Endocrinology, January 1, 1999; 140(1): 273 - 279.
[Abstract] [Full Text]

Home page
 JEMHome page
I. Borcsok, H. U. Schairer, U. Sommer, G. K. Wakley, U. Schneider, F. Geiger, F. U. Niethard, R. Ziegler, and C. H. Kasperk
Glucocorticoids Regulate the Expression of the Human Osteoblastic Endothelin A Receptor Gene
J. Exp. Med., November 2, 1998; 188(9): 1563 - 1573.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society